Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin’s disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208
| Autor: | Patricia A. Ganz, Ting Wang, Jihye Yoon, Oliver W. Press, Richard I. Fisher, Mindy A Bowers, Gretchen S. Gatti, Harry P. Erba, Mark S. Kaminski, Alice B. Kornblith, Ellen R. Gaynor, Joseph M. Unger, Carol M. Moinpour |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male medicine.medical_specialty Randomization Adolescent Symptom Distress Scale Disease Vitality Article law.invention Young Adult 03 medical and health sciences 0302 clinical medicine Quality of life Randomized controlled trial law Survivorship curve Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Survivors 030212 general & internal medicine Stage (cooking) Aged Aged 80 and over Lymphatic Irradiation Oncology (nursing) business.industry Middle Aged Hodgkin Disease Treatment Outcome Oncology 030220 oncology & carcinogenesis Quality of Life Physical therapy Female business Follow-Up Studies |
| Zdroj: | Journal of Cancer Survivorship. 11:32-40 |
| ISSN: | 1932-2267 1932-2259 |
| Popis: | We describe 7 years of follow-up for the energy/vitality outcome in early-stage Hodgkin’s disease patients treated on a randomized clinical trial that compared subtotal lymphoid irradiation (STLI) with combined modality treatment (CMT) (SWOG 9133). Survivorship research questions involved the extent to which symptoms/side effects endured over a follow-up period of 7 years for this early-stage patient group. Two hundred thirty-nine patients participated in the quality of life (QOL) companion study (SWOG 9208) and completed the SF-36 vitality scale, SF-36 health perception item, Cancer Rehabilitation Evaluation System-Short Form (CARES-SF), and symptom distress scale. This paper reports vitality outcome results obtained from randomization, 6 months, and annually for 7 years. To assess changes in vitality over time, we used linear mixed models with patient as a random effect. Patients receiving CMT had lower observed vitality at 6 months than did the STLI patients (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink